Clinical Trial Update: A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis

View source ↗

Summary

This clinical trial update indicates that Janssen-Cilag International NV's safety study of ustekinumab in pediatric participants aged 6 years and older with mod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Psoriasis | Status: ACTIVE_NOT_RECRUITING